Literature DB >> 8077056

The chondroitin sulfate proteoglycan NG2 is a tumour-specific antigen on the chemically induced rat chondrosarcoma HSN.

O Léger1, C Johnson-Léger, E Jackson, B Coles, C Dean.   

Abstract

N-terminal sequences of 19 and 11 amino acids obtained from 2 different tryptic fragments of the tumour-specific antigen on the chemically induced rat chondrosarcoma HSN show a 100% homology with the rat chondroitin sulfate proteoglycan NG2. Using a scheme of overlapping oligonucleotide primers we have cloned by PCR amplification the cDNA for the specific antigen of the HSN tumour that is immunogenic in immunocompetent CBH/Cbi rats and now report that its cDNA sequence is identical to that of NG2. The cDNA codes for a transmembrane protein of 2,325 amino acids with a large extracellular domain of 2,224 amino acids containing 2 cysteine-rich regions, a transmembrane domain (25 amino acids) and a short cytoplasmic tail (76 amino acids). The tumour-specific determinant was found to lie between amino acid residues 556 and 992 on the core glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077056     DOI: 10.1002/ijc.2910580514

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2.

Authors:  D S Barritt; M T Pearn; A H Zisch; S S Lee; R T Javier; E B Pasquale; W B Stallcup
Journal:  J Cell Biochem       Date:  2000-08-02       Impact factor: 4.429

Review 2.  The potential complementary role of targeted alpha therapy in the management of metastatic melanoma.

Authors:  Michael P Brown; Eva Bezak; Barry J Allen
Journal:  Melanoma Manag       Date:  2015-11-24

3.  Human uveal melanoma expresses NG2 immunoreactivity.

Authors:  Y Li; M C Madigan; K Lai; R M Conway; F A Billson; R Crouch; B J Allen
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

4.  Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach.

Authors:  Nicholas T Seyfried; Leanne C Huysentruyt; James A Atwood; Qiangwei Xia; Thomas N Seyfried; Ron Orlando
Journal:  Cancer Lett       Date:  2008-02-20       Impact factor: 8.679

Review 5.  A role for the NG2 proteoglycan in glioma progression.

Authors:  William B Stallcup; Feng-Ju Huang
Journal:  Cell Adh Migr       Date:  2008-07-13       Impact factor: 3.405

6.  NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature.

Authors:  M Talal F Al-Mayhani; Richard Grenfell; Masashi Narita; Sara Piccirillo; Emma Kenney-Herbert; James W Fawcett; V Peter Collins; Koichi Ichimura; Colin Watts
Journal:  Neuro Oncol       Date:  2011-08       Impact factor: 12.300

7.  Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy.

Authors:  Sjoerd P F T Nota; David O Osei-Hwedieh; David L Drum; Xinhui Wang; Francesco Sabbatino; Soldano Ferrone; Joseph H Schwab
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

Review 8.  Targeting CSPG4 for isolation of melanoma cell-derived exosomes from body fluids.

Authors:  S Ferrone; T L Whiteside
Journal:  HNO       Date:  2020-02       Impact factor: 1.284

9.  Differential expression of stem cell-like proteins in normal, hyperplastic and dysplastic oral epithelium.

Authors:  Sarah Mohammed Mohammed Barakat; Chong Huat Siar
Journal:  J Appl Oral Sci       Date:  2015 Jan-Feb       Impact factor: 2.698

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.